Recap: Steris Q3 Earnings

Shares of Steris STE moved higher in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share were up 19.31% over the past year to $1.73, which beat the estimate of $1.52.

Revenue of $808,924,000 rose by 4.48% from the same period last year, which beat the estimate of $792,980,000.

Guidance

Steris hasn't issued any earnings guidance for the time being.

Steris hasn't issued any revenue guidance for the time being.

Recent Stock Performance

52-week high: $203.91

Company's 52-week low was at $105.69

Price action over last quarter: Up 8.33%

Company Overview

Steris is a U.K.-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.